Wilson Sonsini Goodrich & Rosati acted as Dida’s U.S. and Hong Kong counsel in the IPO and SEHK listing. China ride-sharing app operator Dida Inc. (Dida)...
Dida’s IPO and SEHK Listing
Yan Palace’s Initial Public Offering
Wilson Sonsini Goodrich & Rosati acted U.S. and Hong Kong counsel to Xiamen Yan Palace Bird’s Nest Industry Co., Ltd. in the IPO and SEHK listing....
Edianyun Limited’s Hong Kong IPO
Harneys acted as Cayman Islands counsel to Edianyun Limited on the transaction, while Wilson Sonsini Goodrich & Rosati acted as U.S. and Hong Kong counsel to...
QuantaSing’s $40 Million IPO
Wilson Sonsini represented QuantaSing, while Latham & Watkins advised the joint bookrunners on the offering. QuantaSing Group Limited announced the pricing of its initial public offering...
Fenbi’s HK$198 Million Listing on The HKSE
Cooley advised the underwriters involved in the listing while Wilson Sonsini Goodrich & Rosati represented Fenbi. Fenbi, an internet-born test preparation company, proposed the listing of...
Matter YS Biopharma’s Merger with Summit Healthcare Acquisition Corp.
Wilson Sonsini represented YS Biopharma on the deal. YishengBio Co., Ltd (YS Biopharma), a commercialization-stage biopharmaceutical company focusing on innovative vaccines and therapeutic biologics, and Summit...